FDA
approval
· 2018-08-31
FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
Summary
The FDA approved Bayer's supplemental application for Betaseron (interferon beta-1b), updating the product labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BETASERON (INTERFERON BETA-1B)